61
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Plasma glucose reference intervalin a low-risk population. 2. Impact ofthe new WHO and ADA recommendations on the diagnosis of diabetes mellitus

Pages 181-190 | Published online: 08 Jul 2009

  • King H, Rewers M, WHO Ad hoc diabetes reporting group. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 1993; 16: 157–7.
  • WHO. The World Health Report 1998. World Health Organization, Geneva 1998.
  • The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report on the expert committee on the diagnosis and classifi-cation of diabetes mellitus. Diabetes Care 1997; 20: 1183–97.
  • World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its com-plications. Part 1: Diagnosis and classification of diabetes mellitus. WHO, Geneva 1999 (WHO/ N CD/N CS/99.2).
  • McCance DR, Hanson FL, Charles M -A, Jacobsen LTH, Pettitt DJ, Bennett PH, Knowler WC. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concen-trations as diagnostic methods for diabetes. Br Med J 1994; 308: 1323–8.
  • DECODE Study Group. Will new diagnostic cri-teria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. Br Med J 1998; 317: 371–5.
  • Unwin N, Alberti KG, Bhopal R, Harland J, Watson W, White M. Comparison of the current WHO and new ADA criteria for the diagnosis of diabetes mellitus in three ethnic groups in the UK. Diabetic Med 1998; 15: 554–7.
  • Cummings ST, Frazer CG. Variability of capillary plasma glucose in healthy individuals in repeated 75 g oral glucose tolerance test. Ann Clin Biochem 1988; 25: 634–7.
  • American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 1998; 21, Suppl 1: S20—S2.
  • Alberti KGMM, Zimmet PZ, for the WHO Consultation. Definition, diagnosis and classifi-cation of diabetes mellitus and its complication. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report. Diabetic Med 1998; 15: 539–53.
  • Gibb I, Parnham A, Fonfrede M, Lecock F. Multicenter evaluation of Tosoh glycohemoglobin analyzer. Clin Chem 1999; 45: 1833–41.
  • Stahl M, Jorgensen LGM, Hyltoft Petersen P, Brandslund I, Olivarius N de F, Borch-Johnsen K. Optimization of preanalytical conditions and analysis of plasma glucose. 1. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus. Scand J Clin Lab Invest 2001; 61: 169–180.
  • Diabetes Control and Complication Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mel-litus. N Engl J Med 1993; 329: 977–86.
  • Weykamp CW, Pender TJ, Muskiat FAJ, Slik W van der. Evaluation of a reference material for glycated haemoglobin. Eur J Clin Chem Clin Biochem 1996; 34: 67–72.
  • Gowans EMS, Hyltoft Petersen P, Blaabjerg 0, Horder M. Analytical goals for the acceptance of common reference intervals for laboratories throughout a geographical area. Scand J Clin Lab Invest 1988;48: 757–64.
  • Hyltoft Petersen P, Gowans EMS, Blaabjerg 0, Horder M. Analytical goals for the estimation of non-Gaussian reference intervals. Scand J Clin Lab Invest 1989; 49: 727–37.
  • Blaabjerg 0, Norgaard I, Blom M, Rahbek NOrgaard J, Hyltoft Petersen P, Gry H, Uldall A. Reference intervals based on a Danish population. In: Hyltoft Petersen P, Blaabjerg 0, Irjala K, editors. Assessing quality in measurements of plasma proteins. The Nordic protein project and related projects. Upsala J Med Sci 1994;99: 315–38 (also published as NORDKEM. Nordic Clinical Chemistry Project, Helsinki, Finland 1994:125–48)
  • Center for Disease Control and Prevention. Healthy people 2000. US Department of Health and Human Services. 1994.
  • Costongs GMPJ, Janson PCW, Bas BM, Hermans J, Wersch JWJ van, Brombacher PJ. Short-term and long-term intra-individual variations and criti-cal difference of clinical chemical laboratory par-ameters. J Clin Chem Clin Biochem 1995; 23: 7–16
  • Lebovitz HE. Type 2 diabetes: An overview. Clin Chem 1999; 8: 1339–45.
  • Engelgau MM, Kenny SJ, Thompson TJ, Badran A, Herman WH, Sous ES, Boyle JP, Ali MA, Aubert RE. Comparison of fasting and 2-hour glucose and HbAie levels for diagnosing diabetes. Diabetes Care 1997; 20: 785–91.
  • Solberg HE. Approved recommendation (1987) on the theory of reference values. Part 5. Statistical treatment of collected reference values. Determination of reference limits. J Clin Chem Clin Biochem 1987; 25: 645–56.
  • NCCLS. How to define and determine reference intervals in a clinical laboratory; approved guide-lines. NCCLS document 1995; C28-A, vol. 15, no. 4.
  • Harris EK, Boyd JC. On dividing reference data into subgroups to produce separate reference ranges. Clin Chem 1990; 36: 265–70.
  • Harris EK, Wong ET, Shaw ST. Statistical criteria for separate reference intervals: race and gender groups in creatine kinase. Clin Chem 1991; 37: 1580–2.
  • Hyltoft Petersen P, Blaabjerg 0. Reference inter-vals for plasma proteins. Upsala J Med Sci 1994; 99: 307–14.
  • Altman DG. Confidence intervals. In: Sackett DL, Richardson WS, Rosenberg W, Haynes RB, edi-tors. Evidence-based medicine. How to practice and teach EBM. Edinburgh: Churchill Livingstone; 1997. p. 227–34
  • Gardner MJ, Altman DG. Statistics with confi-dence. Confidence intervals and statistical guide-lines. Br Med J 1989.
  • World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on Obesity. WHO, Geneva 1997 (WHO/NU T/NCD/98.1).
  • Gall M-A, Hougaard P, Broch-Johansen K, Parving H-H. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: pro-spective, observational study. Br Med J 1997; 314: 783–8
  • Shapiro ET, Polonsky KS, Copinschi G, Bosson D, Tillil H, Blackman J, Lewis G, Cauter EV. Nocturnal elevation of glucose levels during fasting in noninsulin-dependent diabetes. J Clin Endocrinol Metab 1991;72: 444–54.
  • Klachko DM, Lie TH, Cunningham EJ, Chase CR, Burns TW. Blood glucose levels during walk-ing in normal and diabetic subjects. Diabetes 1972; 21: 89–100.
  • Felding P, Tryding N, Hyltoft Petersen P, HOrder M. Effect of posture on the concentrations of blood constituents in healthy adults: practical application of blood specimen collection procedures rec-ommended by the Scandinavian Committee on Reference Values. Scand J Clin Lab Invest 1980; 40: 615–22.
  • Hyltoft Petersen P, Brandslund I, Jorgensen L, Stahl M, de Fine Olivarius N, Borch-Johnsen K. Effects of analytical and pre-analytical systematic and random factors in measurements of fasting plasma glucose and thereby on the diagnosis of diabetes. The impact of the new WHO and ADA recommendation on diagnosis of diabetes mellitus III. Submitted.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.